Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-09-27 4:15 pm Sale |
2021-09-23 | 13D | I-Mab IMAB |
HHLR Advisors, Ltd. | 16,520,560 9.300% |
-2,530,000 (-13.28%) |
Filing History |
| 2021-09-27 4:10 pm Purchase |
2021-04-30 | 13G | Smart Share Global Limited EM |
HHLR Advisors, Ltd. | 62,627,893 14.700% |
62,627,893 (New Position) |
Filing History |
| 2021-07-19 4:05 pm Sale |
2021-07-15 | 13D | Enstar Group Limited ESGR |
HHLR Advisors, Ltd. | 0 0.000% |
-543,487 (Position Closed) |
Filing History |
| 2021-06-24 06:56 am Unchanged |
2021-06-18 | 13D | I-Mab IMAB |
HHLR Advisors, Ltd. | 19,050,560 11.300% |
0 (Unchanged) |
Filing History |
| 2021-04-22 09:15 am Sale |
2021-04-20 | 13D | CHINA BIOLOGIC PRODS HLDGS INC CBPO |
HHLR Advisors, Ltd. | 0 0.000% |
-2,962,076 (Position Closed) |
Filing History |
| 2021-03-25 4:25 pm Sale |
2021-03-23 | 13D | I-Mab IMAB |
HHLR Advisors, Ltd. | 19,050,560 11.300% |
-3,442,042 (-15.30%) |
Filing History |
| 2021-02-16 4:27 pm Purchase |
2020-12-31 | 13G | Aligos Therapeutics, Inc. ALGS |
HHLR Advisors, Ltd. | 86,603 5.700% |
86,603 (New Position) |
Filing History |
| 2021-02-16 4:25 pm Purchase |
2020-12-31 | 13G | Leap Therapeutics, Inc. LPTX |
HHLR Advisors, Ltd. | 371,624 6.200% |
371,624 (New Position) |
Filing History |
| 2021-02-16 4:24 pm Purchase |
2020-12-31 | 13G | Kiniksa Pharmaceuticals, Ltd. KNSA |
HHLR Advisors, Ltd. | 2,920,023 9.200% |
1,024,135 (+54.02%) |
Filing History |
| 2021-02-16 4:22 pm Sale |
2020-12-31 | 13G | VIELA BIO INC VIE |
HHLR Advisors, Ltd. | 2,382,414 4.300% |
-2,208,762 (-48.11%) |
Filing History |
| 2021-02-16 4:20 pm Sale |
2020-12-31 | 13G | Bilibili Inc. BILI |
HHLR Advisors, Ltd. | 5,067,027 2.100% |
-5,148,328 (-50.40%) |
Filing History |
| 2021-02-16 4:20 pm Purchase |
2020-12-31 | 13G | MINISO Group Holding Limited MNSO |
HHLR Advisors, Ltd. | 60,401,152 6.800% |
60,401,152 (New Position) |
Filing History |
| 2021-02-16 4:20 pm Purchase |
2020-12-31 | 13G | Root, Inc. ROOT |
HHLR Advisors, Ltd. | 248,273 7.290% |
248,273 (New Position) |
Filing History |
| 2021-02-16 4:19 pm Sale |
2020-12-31 | 13G | iQIYI, Inc. IQ |
HHLR Advisors, Ltd. | 270,539,345 10.300% |
-56,323,064 (-17.23%) |
Filing History |
| 2021-02-16 4:18 pm Purchase |
2020-12-31 | 13G | Beam Therapeutics Inc. BEAM |
HHLR Advisors, Ltd. | 2,966,403 5.100% |
2,966,403 (New Position) |
Filing History |
| 2021-02-16 4:14 pm Purchase |
2020-12-31 | 13G | KE Holdings Inc. BEKE |
HHLR Advisors, Ltd. | 176,255,685 6.600% |
176,255,685 (New Position) |
Filing History |
| 2021-02-16 4:10 pm Purchase |
2020-12-31 | 13G | Gossamer Bio, Inc. GOSS |
HHLR Advisors, Ltd. | 7,420,974 9.800% |
1,509,433 (+25.53%) |
Filing History |
| 2021-02-16 4:09 pm Purchase |
2020-12-31 | 13G | Apellis Pharmaceuticals, Inc. APLS |
HHLR Advisors, Ltd. | 5,028,289 6.600% |
350,000 (+7.48%) |
Filing History |
| 2021-02-16 4:06 pm Purchase |
2020-12-31 | 13G | Futu Holdings Limited FUTU |
HHLR Advisors, Ltd. | 1,200,000 0.200% |
1,200,000 (New Position) |
Filing History |
| 2021-02-16 4:06 pm Sale |
2020-12-31 | 13G | Yatsen Holding Limited YSG |
HHLR Advisors, Ltd. | 68,456,810 20.100% |
-1,692,084 (-2.41%) |
Filing History |